Brief: Initiator Pharma Q2 Operating Loss Narrows To At DKK 8.9 Mln
Aug 25 (Reuters) - Initiator Pharma A/S INIT.ST :
* Q2 OPERATING LOSS DKK 8.9 MILLION VERSUS LOSS DKK 13.5
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN7tPC0X
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Reports Q2 EBIT Of DKK -9.5 Million
Brief: EPO Grants Patents To Initiator Pharma For Pain Treatment And Oral Formulation
Brief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00